Last week, readers were most interested in a story about Lumos Dx's completion of a clinical trial for its FebriDx test and the submission of it for CLIA waiver.

UCLA's Electric Field-Induced Release and Measurement (EFIRM) system could offer the early detection of cancers and other ...

TBI is a potential new application area for the 8-year-old company, while it continues to commercialize its stroke triage ...

The company's laboratory-developed test (LDT) for neurofilament light chain (NfL) also gained New York state approval as part of the permitting process.

The program offers lower-cost, refurbished testing instruments as well as customer education, inventory management, and enhanced service agreements.

Financial and other terms of the deal were not disclosed.

Reviewers winnowed an initial 27 assays to a group of nine that were evaluated using NCI sample sets, ultimately choosing ClearNote's Avantect and Guardant's Shield.

The MMR IHC Panel PharmaDx (Dako Omnis) is used to identify loss of function in mismatch repair proteins and inform the treatment of colorectal cancer patients.

NEW YORK — The Scottish government has earmarked £800,000 ($1.1 million) to support the introduction of a Genedrive test to help prevent antibiotic-induced deafness in newborns within the country, ...

The all-virtual program is currently looking for a second cohort of novel diagnostics technologies, with a Sept. 30 deadline for new applications.

The organization noted that US senators have introduced a bill to accelerate Medicare coverage for breakthrough devices.